MHRA approves Casgevy, the first CRISPR gene therapy for Sickle Cell Disease and Beta-Thalassemia by Editor | Nov 17, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, Science, Technology & Research | 0 UNITED KINGDOM—After conducting a comprehensive evaluation of its safety, quality, and... Read More
Arbor Biotechnologies clinches US$215 Million Series B funding to upscale precision editing therapeutics by Editor | Nov 10, 2021 | Hospitals, LATEST NEWS, Mergers, Investments & Funding, Science, Technology & Research, WORLD NEWS | 0 USA – Arbor Biotechnologies, a genome-editing company discovering and developing the next... Read More